Combination of Brivanib With 5-Fluorouracil/Leucovorin (5FU/LV) and 5-Fluorouracil/Leucovorin/Irinotecan (FOLFIRI)

NCT01046864 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

49

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastro-Intestinal Cancer

Interventions

DRUG: 5-FU
DRUG: Leucovorin
DRUG: 5-FU
DRUG: Irinotecan
DRUG: Brivanib
DRUG: Brivanib
DRUG: Brivanib

Sponsor

Bristol-Myers Squibb